Abstract
The finding that canonical and nuclear mTOR signaling pathways control distinct gene programs opens therapeutic opportunities to modulate mTOR activity in prostate cancer cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have